McDonnell T J, Meyn R E, Robertson L E
Department of Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Semin Cancer Biol. 1995 Feb;6(1):53-60. doi: 10.1006/scbi.1995.0007.
The process of programmed cell death, or apoptosis, is now recognized as an important component of multistep carcinogenesis. Traditionally, interventions used in the treatment of cancer patients were predicated on enhanced rates of proliferation in the tumor cells. It is now appreciated that tumor growth may, in many circumstances, be more a function of reduced rates of cell death rather than enhanced proliferation per se. Our understanding of the molecular regulation of apoptotic cell death is leading to the design and implementation of treatment strategies based on cell death induction.
程序性细胞死亡或凋亡过程,如今被视为多步骤致癌作用的一个重要组成部分。传统上,用于治疗癌症患者的干预措施是基于提高肿瘤细胞的增殖速率。现在人们认识到,在许多情况下,肿瘤生长可能更多地取决于细胞死亡速率的降低,而非增殖本身的增强。我们对凋亡性细胞死亡分子调控的理解,正促使基于诱导细胞死亡的治疗策略得以设计和实施。